You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
愛朋醫療(300753.SZ):上半年淨利預降15%-25%
格隆匯 07-14 16:59

格隆匯 7 月 14日丨愛朋醫療(300753.SZ)披露2020年半年度業績預告,預計歸屬於上市公司股東的淨利潤3090.96萬元-3503.09萬元,同比下降15%-25%。業績變動原因如下:

1、報告期內,公司圍繞2020年度經營目標和工作計劃,在新冠肺炎疫情這一重大突發不利影響之下,努力推進各項工作。報告期淨利潤同比下降的主要原因如下:

(1)一季度受新冠肺炎疫情影響,公司延期復工。復工後銷售、研發、行政管理等業務崗位較長時間以遠程辦公為主,市場和銷售人員無法正常開展商務交流、新客户開發、臨牀服務等工作,公司整個經營管理受到影響。同時,受疫情影響全國各地醫療機構門診量、手術量同比顯著下降,公司主營產品微電腦注藥泵、鼻腔護理噴霧器整體採購需求下降,對公司銷售業績造成較大影響。

(2)二季度,隨着國內疫情防控取得階段性進展,公司積極調整經營策略以順應外部環境變化和內部發展需求,有序推進銷售推廣工作,整體業績恢復至上年同期水平。

2、報告期內,預計非經常性損益對公司歸屬於上市公司股東淨利潤的影響金額為450萬元-550萬元,主要為公司取得的投資收益、政府補助資金等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account